IPRATROPIUM BROMIDE spray, metered

देश: संयुक्त राज्य

भाषा: अंग्रेज़ी

स्रोत: NLM (National Library of Medicine)

सक्रिय संघटक:

IPRATROPIUM BROMIDE (UNII: J697UZ2A9J) (IPRATROPIUM - UNII:GR88G0I6UL)

थमां उपलब्ध:

Bausch & Lomb Incorporated

INN (इंटरनेशनल नाम):

IPRATROPIUM BROMIDE

रचना:

IPRATROPIUM BROMIDE ANHYDROUS 21 ug

प्रशासन का मार्ग:

NASAL

प्रिस्क्रिप्शन प्रकार:

PRESCRIPTION DRUG

चिकित्सीय संकेत:

Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis in adults and children age 6 years and older. Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) does not relieve nasal congestion, sneezing, or postnasal drip associated with allergic or nonallergic perennial rhinitis. Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is contraindicated in patients with a history of hypersensitivity to atropine or its derivatives, or to any of the other ingredients. Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) 21 mcg/spray Rx only Read complete instructions carefully before using.   In order to ensure proper dosing, do not attempt to change the size of the spray opening. Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is indicated for the symptomatic relief of rhinorrhea (runny nose) associated with allergic and nonallergic perennial rhinitis in adults and children age 6 years and older. Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) does not relieve nasal congestion, sneezing, or postnasal drip associated with allergic or nonallergic perennial rhinitis. Read complete instructions carefully and use only as directed. To Use: 1. Remove the plastic dust cap and the safety clip from the nasal spray pump (Figure 1). The safety clip prevents the accidental discharge of the spray in your pocket or purse. 2. The nasal spray pump must be primed before Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is used for the first time. To prime the pump, hold the bottle with your thumb at the base and your index and middle fingers on the white shoulder area. Make sure the bottle points upright and away from your eyes. Press your thumb firmly and quickly against the bottle seven (7) times (Figure 2). The pump is now primed and can be used. Your pump should not have to be reprimed unless you have not used the medication for more than 24 hours; repriming the pump will only require two sprays. If you have not used your nasal spray for more than seven (7) days, repriming the pump will require seven sprays. 3. Before using Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray), blow your nose gently to clear your nostrils if necessary. 4. Close one nostril by gently placing your finger against the side of your nose, tilt your head slightly forward and, keeping the bottle upright, insert the nasal tip into the other nostril (Figure 3). Point the tip toward the back and outer side of the nose. 5. Press firmly and quickly upwards with the thumb at the base while holding the white shoulder portion of the pump between your index and middle fingers. Following each spray, sniff deeply and breathe out through your mouth. 6. After spraying the nostril and removing the unit, tilt your head backwards for a few seconds to let the spray spread over the back of the nose. 7. Repeat steps 4 through 6 in the same nostril. 8. Repeat steps 4 through 7 in the other nostril (i.e., two sprays per nostril). 9. Replace the plastic dust cap and safety clip. 10. At some time before the medication is completely used up, you should consult your physician or pharmacist to determine whether a refill is needed. You should not take extra doses or stop using Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) without consulting your physician. To Clean: If the nasal tip becomes clogged, remove the plastic dust cap and safety clip. Hold the nasal tip under running, warm tap water (Figure 4) for about a minute. Dry the nasal tip, reprime the nasal spray pump (step 2 above), and replace the plastic dust cap and safety clip.   Caution: Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is intended to relieve your rhinorrhea (runny nose) with regular use. It is therefore important that you use Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) as prescribed by your physician. For most patients, some improvement in runny nose is usually apparent during the first full day of treatment with Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray). Some patients may require up to two weeks of treatment to obtain maximum benefit. Do not spray Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) in your eyes. Should this occur, immediately flush your eye with cool tap water for several minutes. If you accidentally spray Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) in your eyes, you may experience a temporary blurring of vision, visual halos or colored images in association with red eyes from conjunctival and corneal congestion, development or worsening of narrow-angle glaucoma, pupil dilation, or acute eye pain/discomfort, and increased sensitivity to light, which may last a few hours. Should acute eye pain or blurred vision occur, contact your doctor. Should you experience excessive nasal dryness or episodes of nasal bleeding, contact your doctor. If you have glaucoma or difficulty urinating due to an enlargement of the prostate, be sure to tell your physician prior to using Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray). If you are pregnant or you are breast feeding your baby, be sure to tell your physician prior to using Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray). STORAGE: Store at 68° to 77°F (20° to 25°C); excursions are permitted to 59° to 86°F (15° to 30°C). Avoid freezing. Keep out of reach of children. To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-321-4576 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Distributed by: Bausch + Lomb, a division of Bausch Health US, LLC Bridgewater, NJ 08807 USA Manufactured by: Bausch Health Companies Inc. Laval, Quebec H7L 4A8, Canada © 2019 Bausch & Lomb Incorporated or its affiliates Revised: May 2019 9682401 (Folded)

उत्पाद समीक्षा:

Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is supplied as 30 mL of solution in a high density polyethylene (HDPE) bottle fitted with a metered nasal spray pump, a safety clip to prevent accidental discharge of the spray, and a plastic dust cap. It contains 31.1 g of product formulation, 345 sprays, each delivering 21 mcg (70 microliters) of ipratropium per spray, or 28 days of therapy at the maximum recommended dose (two sprays per nostril three times a day).

प्राधिकरण का दर्जा:

Abbreviated New Drug Application

उत्पाद विशेषताएं

IPRATROPIUM BROMIDE- IPRATROPIUM BROMIDE SPRAY, METERED
BAUSCH & LOMB INCORPORATED
----------
IPRATROPIUM BROMIDE NASAL SOLUTION
0.03% (NASAL SPRAY 21 MCG SPRAY)
ATTENTION PHARMACIST: DETACH “PATIENT’S INSTRUCTIONS FOR USE”
FROM PACKAGE INSERT AND DISPENSE WITH THE PRODUCT.
RX ONLY
DESCRIPTION:
The active ingredient in Ipratropium Bromide Nasal Solution 0.03%
(Nasal Spray) is
ipratropium bromide monohydrate. It is an anticholinergic agent
chemically described as
8-azoniabicyclo[3.2.1] octane, 3-(3-hydroxy-1-oxo-2
phenylpropoxy)-8-methyl-8-(1-
methylethyl)-, bromide monohydrate (3-endo, 8-syn)-: a synthetic
quaternary
ammonium compound, chemically related to atropine. Its structural
formula is:
ipratropium bromide monohydrate
C
H
BrNO • H O Mol. Wt. 430.4
Ipratropium bromide is a white to off-white crystalline substance,
freely soluble in water
and methanol, sparingly soluble in ethanol, and insoluble in non-polar
media. In aqueous
solution, it exists in an ionized state as a quaternary ammonium
compound.
Ipratropium Bromide Nasal Solution 0.03% (Nasal Spray) is a
metered-dose, manual
pump spray unit which delivers 21 mcg (70 microliters) ipratropium
bromide per spray
on an anhydrous basis in an isotonic, aqueous solution, with
pH-adjusted to 4.7 with
hydrochloric acid and/or sodium hydroxide (if needed). It also
contains benzalkonium
chloride, edetate disodium, sodium chloride and purified water. Each
bottle contains 345
sprays.
CLINICAL PHARMACOLOGY:
MECHANISM OF ACTION:
Ipratropium bromide is an anticholinergic (parasympatholytic) agent
which, based on
animal studies, appears to inhibit vagally-mediated reflexes by
antagonizing the action of
acetylcholine, the transmitter agent released at the neuromuscular
junctions in the lung.
In humans, ipratropium bromide has anti-secretory properties and, when
applied locally,
20
30
3
2
inhibits secretions from the serous and seromucous glands lining the
nasal mucosa.
Ipratropium bromide is a quaternary amine that minimally crosses the
nasal and
gastrointestinal m